SCHEMBL5864252

SCHEMBL5864252

c1ccc(COc2ccc(NCc3cccc(OC4CCCCO4)c3)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.55
MAPT P10636 5/20 0.55
KMT2A Q03164 5/20 0.55
BLM P54132 3/20 0.55
RAB9A P51151 3/20 0.55
ALDH1A1 P00352 3/20 0.55
L3MBTL1 Q9Y468 3/20 0.55
GAA P10253 2/20 0.55
THRB P10828 2/20 0.55
PKM P14618 2/20 0.55
KDM4E B2RXH2 1/20 0.55
FFAR1 O14842 2/20 0.50
TP53 P04637 1/20 0.48
ATM Q13315 1/20 0.48
DHFR P00374 1/20 0.48
LMNA P02545 2/20 0.46
RECQL P46063 1/20 0.46
CASP6 P55212 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
MRGPRX1 Q96LB2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5863905 0.85 DHFR (0.48) MEN1MAPTKMT2ABLMRAB9A
SCHEMBL27252707 0.84 DHFR (0.54) DHFRBCHEMAOB
SCHEMBL5863673 0.83 LTA4H (0.59) ALDH1A1KDM4EDHFRLTA4HSMN1; SMN2
SCHEMBL8601010 0.83 LMNA (0.46) MEN1MAPTKMT2ARAB9AL3MBTL1
SCHEMBL19556828 0.82 DHFR (0.45) MEN1KMT2ARAB9ADHFRLMNA
SCHEMBL7264789 0.80 HRH3 (0.50) MEN1MAPTKMT2ABLMALDH1A1
SCHEMBL8601201 0.79 LMNA (0.47) MAPTRAB9AL3MBTL1GAALMNA
SCHEMBL5863921 0.78 KDM4E (0.50) MEN1MAPTKMT2ABLMALDH1A1
SCHEMBL31473767 0.75 CYP1A2 (0.51) MEN1MAPTKMT2ARAB9AL3MBTL1
SCHEMBL6768580 0.75 SRD5A2 (0.56) MEN1MAPTKMT2ARAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7053212-B2 Acyclic amide and sulfonamide ligands for the estrogen receptor PFIZER INC. (US) 2006-05-30 US disclosed
EP-1542967-A1 AMIDE AND SULFONAMIDE LIGANDS FOR THE ESTROGEN RECEPTOR Pfizer Products Inc. (US) 2005-06-22 EP disclosed
US-20040110767-A1 Acyclic amide and sulfonamide ligands for the estrogen receptor PFIZER INC 2004-06-10 US disclosed
WO-2004026823-A1 AMIDE AND SULFONAMIDE LIGANDS FOR THE ESTROGEN RECEPTOR PFIZER PRODUCTS INC. (US) 2004-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110767-A1 Acyclic amide and sulfonamide ligands for the estrogen receptor GHSR, GPER1, SSTR1 MEN1 1282/4885MAPT 4755/4885KMT2A 2144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.